Logo image of EKOP.BR

EKOPAK NV (EKOP.BR) Stock Fundamental Analysis

EBR:EKOP - BE0974380124 - Common Stock

6.54 EUR
-0.16 (-2.39%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

2

Overall EKOP gets a fundamental rating of 2 out of 10. We evaluated EKOP against 41 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of EKOP have multiple concerns. EKOP is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year EKOP has reported negative net income.
EKOP had a negative operating cash flow in the past year.
EKOP had negative earnings in each of the past 5 years.
EKOP had negative operating cash flow in 4 of the past 5 years.
EKOP.BR Yearly Net Income VS EBIT VS OCF VS FCFEKOP.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

The Return On Assets of EKOP (-7.84%) is worse than 69.05% of its industry peers.
The Return On Equity of EKOP (-29.69%) is worse than 71.43% of its industry peers.
Industry RankSector Rank
ROA -7.84%
ROE -29.69%
ROIC N/A
ROA(3y)-4.22%
ROA(5y)-2.9%
ROE(3y)-12.98%
ROE(5y)-8.4%
ROIC(3y)N/A
ROIC(5y)N/A
EKOP.BR Yearly ROA, ROE, ROICEKOP.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200 250

1.3 Margins

Looking at the Gross Margin, with a value of 30.21%, EKOP is doing worse than 64.29% of the companies in the same industry.
EKOP's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for EKOP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.64%
GM growth 5Y-5.79%
EKOP.BR Yearly Profit, Operating, Gross MarginsEKOP.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

0

2. Health

2.1 Basic Checks

EKOP does not have a ROIC to compare to the WACC, probably because it is not profitable.
EKOP has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, EKOP has more shares outstanding
EKOP has a worse debt/assets ratio than last year.
EKOP.BR Yearly Shares OutstandingEKOP.BR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 5M 10M
EKOP.BR Yearly Total Debt VS Total AssetsEKOP.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

EKOP has an Altman-Z score of 0.36. This is a bad value and indicates that EKOP is not financially healthy and even has some risk of bankruptcy.
EKOP has a Altman-Z score of 0.36. This is in the lower half of the industry: EKOP underperforms 69.05% of its industry peers.
A Debt/Equity ratio of 1.30 is on the high side and indicates that EKOP has dependencies on debt financing.
EKOP has a Debt to Equity ratio of 1.30. This is in the lower half of the industry: EKOP underperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.3
Debt/FCF N/A
Altman-Z 0.36
ROIC/WACCN/A
WACC6.29%
EKOP.BR Yearly LT Debt VS Equity VS FCFEKOP.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

A Current Ratio of 0.80 indicates that EKOP may have some problems paying its short term obligations.
The Current ratio of EKOP (0.80) is worse than 73.81% of its industry peers.
A Quick Ratio of 0.64 indicates that EKOP may have some problems paying its short term obligations.
The Quick ratio of EKOP (0.64) is worse than 73.81% of its industry peers.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.64
EKOP.BR Yearly Current Assets VS Current LiabilitesEKOP.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

7

3. Growth

3.1 Past

The earnings per share for EKOP have decreased strongly by -288.77% in the last year.
The Revenue has grown by 32.20% in the past year. This is a very strong growth!
EKOP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.09% yearly.
EPS 1Y (TTM)-288.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-249.72%
Revenue 1Y (TTM)32.2%
Revenue growth 3Y61.78%
Revenue growth 5Y36.09%
Sales Q2Q%-30.87%

3.2 Future

Based on estimates for the next years, EKOP will show a very strong growth in Earnings Per Share. The EPS will grow by 60.98% on average per year.
EKOP is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 25.77% yearly.
EPS Next Y22.45%
EPS Next 2Y13.39%
EPS Next 3Y25.99%
EPS Next 5Y60.98%
Revenue Next Year25.15%
Revenue Next 2Y23.27%
Revenue Next 3Y16.96%
Revenue Next 5Y25.77%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
EKOP.BR Yearly Revenue VS EstimatesEKOP.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M
EKOP.BR Yearly EPS VS EstimatesEKOP.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2028 0 0.5 1

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EKOP. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EKOP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EKOP.BR Price Earnings VS Forward Price EarningsEKOP.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EKOP.BR Per share dataEKOP.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

A more expensive valuation may be justified as EKOP's earnings are expected to grow with 25.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.39%
EPS Next 3Y25.99%

0

5. Dividend

5.1 Amount

EKOP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EKOPAK NV

EBR:EKOP (9/5/2025, 7:00:00 PM)

6.54

-0.16 (-2.39%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)09-01 2025-09-01
Earnings (Next)11-04 2025-11-04/amc
Inst Owners0.73%
Inst Owner ChangeN/A
Ins Owners82.57%
Ins Owner ChangeN/A
Market Cap114.45M
Analysts77.78
Price Target5.61 (-14.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.8%
PT rev (3m)2.8%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-78.12%
EPS NY rev (3m)-78.12%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.4
P/FCF N/A
P/OCF N/A
P/B 2.78
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.81
EYN/A
EPS(NY)-0.19
Fwd EYN/A
FCF(TTM)-1.78
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS2.72
BVpS2.35
TBVpS-0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.84%
ROE -29.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.21%
FCFM N/A
ROA(3y)-4.22%
ROA(5y)-2.9%
ROE(3y)-12.98%
ROE(5y)-8.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.64%
GM growth 5Y-5.79%
F-Score2
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 1.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 351.32%
Cap/Sales 57.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.64
Altman-Z 0.36
F-Score2
WACC6.29%
ROIC/WACCN/A
Cap/Depr(3y)366.86%
Cap/Depr(5y)479.35%
Cap/Sales(3y)50.41%
Cap/Sales(5y)51.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-288.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-249.72%
EPS Next Y22.45%
EPS Next 2Y13.39%
EPS Next 3Y25.99%
EPS Next 5Y60.98%
Revenue 1Y (TTM)32.2%
Revenue growth 3Y61.78%
Revenue growth 5Y36.09%
Sales Q2Q%-30.87%
Revenue Next Year25.15%
Revenue Next 2Y23.27%
Revenue Next 3Y16.96%
Revenue Next 5Y25.77%
EBIT growth 1Y-284%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1036.36%
EBIT Next 3Y182.37%
EBIT Next 5Y140.21%
FCF growth 1Y-159.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-474.52%
OCF growth 3YN/A
OCF growth 5YN/A